A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment.

ABSTRACT:

SUBMITTER: Ouyang Y 

PROVIDER: S-EPMC11993195 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature